ABSTRACT
Cytotoxic T-lymphocyte (CTL) responses directed to different human immunodeficiency virus (HIV) epitopes vary in their protective efficacy. In particular, HIV-infected cells are much more sensitive to lysis by anti-Gag/p17(77-85)/HLA-A2 than to that by anti-polymerase/RT(476-484)/HLA-A2 CTL, because of a higher density of p17(77-85) complexes. This report describes multiple processing steps favoring the generation of p17(77-85) complexes: (i) the exact COOH-terminal cleavage of epitopes by cellular proteases occurred faster and more frequently for p17(77-85) than for RT(476-484), and (ii) the binding efficiency of the transporter associated with antigen processing was greater for p17(77-85) precursors than for the RT(476-484) epitope. Surprisingly, these peptides, which differed markedly in their antigenicity, displayed qualitatively and quantitatively similar immunogenicity, suggesting differences in the mechanisms governing these phenomena. Here, we discuss the mechanisms responsible for such differences.
Subject(s)
Antigen Presentation/immunology , Cysteine Endopeptidases , Epitopes, T-Lymphocyte/immunology , Gene Products, gag/immunology , HIV Antigens/immunology , HIV Infections/immunology , HIV Reverse Transcriptase/immunology , HIV-1/immunology , HLA-A2 Antigen/immunology , Immunodominant Epitopes/immunology , Multienzyme Complexes , T-Lymphocytes, Cytotoxic/immunology , Viral Proteins , Amino Acid Sequence , Biological Transport , Endopeptidases/metabolism , Epitopes, T-Lymphocyte/metabolism , Gene Products, gag/metabolism , HIV Antigens/metabolism , HIV Reverse Transcriptase/metabolism , Humans , Immunodominant Epitopes/metabolism , Major Histocompatibility Complex , Molecular Sequence Data , Proteasome Endopeptidase Complex , Protein Precursors/metabolism , Proteins/metabolism , gag Gene Products, Human Immunodeficiency VirusABSTRACT
Expression of tissue kallikrein in human neutrophils has been suggested by previous studies using enzymatic and immunochemical techniques. Secretion of this potent biological factor by neutrophils would be of marked significance in the inflammatory process. The present study utilized the polymerase chain reaction following reverse transcriptase generation of total neutrophils cDNA to demonstrate the presence of tissue kallikrein mRNA in the human neutrophils. In addition, use of sequence-specific primers demonstrated the presence of mRNA for the hGK-1 gene, but not for the hPK gene product or the gene for prostate-specific antigen. These results confirm that tissue kallikrein is present in neutrophils and may be secreted as part of the inflammatory process.
Subject(s)
Kallikreins/genetics , Neutrophils/chemistry , RNA, Messenger/blood , Animals , Base Sequence , Humans , Kallikreins/analysis , Molecular Sequence Data , Oligodeoxyribonucleotides , RNA, Messenger/genetics , Rats , Sequence Homology, Nucleic AcidABSTRACT
There has been major interest in the potential interaction between blood coagulation and inflammation. Most of the effort has focused on cellular interactions involving platelets and polymorphonuclear leukocytes (PMNS). The recent discovery of tissue kallikrein(TK) activity in PMNs prompted the study of the possible role of thrombin(IIa) in this process. Human PMNs were isolated by density gradient centrifugation. Human IIa was compared with fMLP with respect to chemotaxis and enzyme release. Results from the challenges by IIa and fMLP were compared to a NaCl control using Student's paired t-test. IIa was a potent chemotactic agent for PMNs (p less than or equal to 0.0121) and stimulated the release of TK (p less than or equal to 0.0001) as determined by hydrolysis of S-2266. FMLP significantly stimulated PMN chemotaxis (p less than or equal to 0.0028) but had no effect on TK release. Release of TK was confirmed by Western Blot analysis and 35S-methionine incorporation into a 35 KD protein after IIa challenge. These results demonstrate that IIa is chemotactic for PMNs and can cause release of tissue kallikrein demonstrating a direct role for blood coagulation in the regulation of the inflammatory response.
